Nucor Corporation vs Koninklijke Philips NV — how do they compare? Nucor Corporation trades at $248 (market cap $55.84B), while Koninklijke Philips NV trades at $24.38 (market cap $23.52B). The key difference: Nucor Corporation is far larger — about 2.4× Koninklijke Philips NV's market cap, and Koninklijke Philips NV pays the higher dividend (4.17%). Which is the better fit depends on your goals — on Pluang, investors hold Nucor Corporation for 78 Days and Koninklijke Philips NV for 84 Days on average.
| NUE | PHG | |
|---|---|---|
Market Cap | $55.84B | $23.52B |
Volume | 848,835 | 1,635,069 |
Sector | Basic Materials | Health |
52-Week High | $274.74 | $32.91 |
52-Week Low | $131.78 | $23.81 |
Typical Hold Time | 78 Days | 84 Days |
Enterprise Value | $60.25B | $29.87B |
Dividend Yield | 0.91% | 4.17% |
Signals from Pluang's Aura AI — not financial advice
Nucor (NUE) trades at $246.44, down 1.84% on the day, with mixed technical signals showing neutral momentum. The stock has demonstrated strong earnings performance with recent beats in Q1 and Q2 2026, though Q4 2025 missed expectations. Revenue has stabilized around $32.5B after declining from 2022 peaks, while profit margins show recovery signs. Analysts maintain a bullish stance with a $266.88 price target, representing 8% upside potential from current levels.
Nucor presents a balanced investment case with improving fundamentals but faces cyclical steel industry headwinds. The company's dividend king status and strong operational execution support long-term value, while competitive pressures and margin volatility remain key risks. Current valuation appears reasonable with P/E of 19.67 and P/S of 1.57, suggesting potential for moderate growth if steel demand strengthens.
PHG trades at $24.09, down 0.25% on the day, with a bearish technical signal despite recent earnings beats. The company shows improving fundamentals with net income turning positive to $895M in 2025 after previous losses, supported by strong operational cash flow of $1.17B. Recent news highlights product innovations including new CT systems and AI healthcare tools, while institutional investors like Bank of America and Arrowstreet Capital have increased positions.
PHG presents a mixed outlook with solid profitability recovery but technical weakness. The stock offers value at reasonable valuations (P/E 18.84, P/S 1.18) and analyst consensus leans Hold (63.64%). Key risks include cybersecurity threats (Reuters, 2026-08-13) and debt levels, while opportunities lie in healthcare technology expansion and Exor's potential increased stake to 22% (Reuters, 2026-08-11).
Trailing returns across standard periods
Latest headlines on both assets
Nucor Corp manufactures steel and steel products. The company also produces direct reduced iron for use in its steel mills. The operations include international trading and sales companies that buy and sell steel and steel products manufactured by the company and others. The operating business segments are: steel mills, steel products and raw materials, the steel mills segment derives maximum revenue.
Read more on NUE →Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.
Read more on PHG →